Source:http://linkedlifedata.com/resource/pubmed/id/17622965
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-12-5
|
pubmed:abstractText |
Cyclooxygenase (COX) is the rate-limiting enzyme in the production of prostaglandins. COX-2, the predominant COX isoform in brain, is induced by synaptic activity. COX-2-generated prostaglandins are important regulators for a range of activities under physiologic conditions. However, under pathologic conditions, COX-2 activity can produce reactive oxygen species and toxic prostaglandin metabolites that can exacerbate brain injury. In this study, we examine the developmental production of COX-2 and test the ability of a COX-2 inhibitor, SC58125, to attenuate traumatic brain injury in developing rats. We show that constitutive COX-2 concentration is low (0.5-fold adult concentration) during the first postnatal week and then increases to 3-fold of adult levels between days 14-60. Controlled cortical impact (CCI) at postnatal day (PND) 17, but not PND 7, caused an additional 3-fold increase in COX-2 content and was associated with an increase in the COX-2 product PGE2. Treatment with the COX-2 inhibitor SC58125 in PND17 rats exposed to CCI attenuated the rise in PGE2 but did not attenuate lesion volume or improve performance in the Morris water maze.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-((4-methylsulfonyl)phenyl)-3-trifl...,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0031-3998
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
271-6
|
pubmed:dateRevised |
2011-5-5
|
pubmed:meshHeading |
pubmed-meshheading:17622965-Animals,
pubmed-meshheading:17622965-Animals, Newborn,
pubmed-meshheading:17622965-Brain Injuries,
pubmed-meshheading:17622965-Cyclooxygenase 2,
pubmed-meshheading:17622965-Cyclooxygenase Inhibitors,
pubmed-meshheading:17622965-Dinoprostone,
pubmed-meshheading:17622965-Male,
pubmed-meshheading:17622965-Maze Learning,
pubmed-meshheading:17622965-Neuroprotective Agents,
pubmed-meshheading:17622965-Pyrazoles,
pubmed-meshheading:17622965-Rats,
pubmed-meshheading:17622965-Rats, Sprague-Dawley
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cyclooxygenase-2 activity following traumatic brain injury in the developing rat.
|
pubmed:affiliation |
Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA. robert.hickey@chp.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|